The global minimally invasive spine surgery (MISS) devices market was valued at USD 1.38 billion in 2024 and is projected to grow from USD 1.42 billion in 2025 to USD 2.22 billion by 2034, registering a compound annual growth rate (CAGR) of 5.1% during the forecast period.
Market growth is primarily driven by the rising prevalence of spinal disorders and a growing preference for minimally invasive surgical approaches that reduce hospital stays, postoperative pain, and recovery times. Advances in surgical instrumentation, imaging systems, and navigation technologies are further accelerating the adoption of MISS devices across both developed and emerging healthcare markets.
Minimally invasive spine surgery devices enable surgeons to perform complex spinal procedures through smaller incisions, minimizing tissue damage while improving surgical accuracy and patient outcomes. As healthcare systems increasingly prioritize efficiency, cost containment, and faster patient recovery, MISS techniques are gaining traction as an alternative to conventional open spine surgeries.
Key growth drivers
Rising prevalence of spine disorders: Increasing incidences of degenerative spinal conditions, herniated discs, and spinal stenosis—particularly among aging populations—are significantly driving demand for minimally invasive spine interventions.
Growing geriatric population: The expanding elderly demographic is more susceptible to chronic spinal conditions, boosting demand for procedures that offer reduced surgical trauma and faster rehabilitation.
Technological advancements in surgical tools: Continuous innovation in endoscopic systems, spinal implants, navigation platforms, and intraoperative imaging is enhancing procedural precision and broadening the clinical applications of MISS devices.
Shift toward outpatient and same-day surgeries: Minimally invasive techniques support shorter hospital stays and outpatient procedures, aligning with healthcare systems’ efforts to reduce costs and improve patient throughput.
Pitfalls and challenges
High cost of advanced MISS equipment: The significant capital investment required for specialized surgical tools, imaging systems, and navigation platforms limits adoption in smaller hospitals and cost-sensitive markets.
Shortage of skilled surgeons in developing regions: MISS procedures demand specialized training and expertise, and the lack of adequately trained spine surgeons in emerging economies constrains market expansion.
Despite these challenges, manufacturers are increasingly focusing on surgeon training programs, modular device platforms, and cost-optimized solutions to improve accessibility and adoption across diverse healthcare settings.
Regional insights
North America dominated the global minimally invasive spine surgery devices market in 2024, accounting for a 35.3% share. Regional growth is supported by a high prevalence of degenerative spinal disorders, well-established healthcare infrastructure, and widespread adoption of advanced surgical technologies.
The U.S. remains the largest contributor to regional revenue. The U.S. market was valued at USD 431.7 million in 2021 and USD 437.1 million in 2022, reaching USD 443.4 million in 2023 and USD 452.3 million in 2024. This steady growth is driven by increasing procedure volumes, favorable reimbursement for minimally invasive techniques, and strong presence of leading spine device manufacturers.
Outlook
The minimally invasive spine surgery devices market is expected to witness steady growth through 2034, supported by rising spinal disease burden, ongoing technological innovation, and increasing patient preference for less invasive surgical options. Companies that invest in surgeon education, cost-effective device development, and expansion into emerging markets are likely to strengthen their competitive positioning in this evolving orthopedic and neurosurgical landscape.
Source: https://www.gminsights.com/industry-analysis/minimally-invasive-spine-surgery-devices-market
Image: Canva
